Sale!

Cancer Targeted Gene Panel Colon Colorectal Test

Original price was: 3,960 د.إ.Current price is: 2,970 د.إ.

-25%

The “Cancer Targeted Gene Panel Colon Colorectal Test” is a sophisticated diagnostic tool offered by DNA Labs UAE, designed to detect genetic mutations associated with colon and colorectal cancer. Priced at 2970 AED, this test analyzes a specific set of genes known to be linked to the risk and progression of colorectal cancer, providing valuable insights into an individual’s genetic predisposition to this type of cancer. By targeting these genes, the test can help in the early detection of cancerous cells, guide treatment decisions, and offer predictions about treatment response and prognosis. This personalized approach to cancer diagnosis and management represents a significant advancement in the fight against colorectal cancer, enabling more tailored and effective treatment strategies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Cancer Targeted Gene Panel Colon Colorectal Test

Test Cost: AED 2970.0

Symptoms, Diagnosis, and Referring Details

Test Name: CANCER TARGETED GENE PANEL COLON COLORECTAL Test

Components:

  • Microsatellite Instability Panel
  • KRAS
  • BRAF
  • PIK3CA
  • PTEN

Price: 2970.0 AED

Sample Condition: Submit Formalin fixed paraffin embedded tissue block. Ship at room temperature. Tissue block must contain at least 10% tumor tissue. Duly filled NGS Test Requisition Form is mandatory.

Report Delivery: Sample due by 9 am; Report within 10 working days

Method: Immunohistochemistry, NGS

Test Type: Cancer

Doctor: Oncologist

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information: Duly filled NGS Test Requisition Form is mandatory.

Test Details

The Cancer Targeted Gene Panel: Colon/Colorectal Test is a genetic test that analyzes specific genes associated with colon and colorectal cancer. It is used to identify mutations or alterations in these genes that may increase an individual’s risk of developing these types of cancer.

This test typically examines a panel of genes that are known to be involved in the development and progression of colon and colorectal cancer. These genes may include APC, KRAS, BRAF, PIK3CA, and others.

By analyzing these genes, the test can provide information about the presence of specific mutations or alterations that may be linked to an increased risk of developing colon or colorectal cancer.

The results of this test can help healthcare providers make more informed decisions regarding an individual’s risk of developing these types of cancer. It can also guide treatment options and provide valuable information for personalized medicine approaches.

It is important to note that this test is typically performed on individuals who have a personal or family history of colon or colorectal cancer, or those who have other risk factors for these types of cancer. It is not a screening test for the general population.

As with any genetic test, it is recommended to discuss the potential benefits, limitations, and implications of the test with a healthcare provider or genetic counselor before undergoing testing.

Test Name CANCER TARGETED GENE PANEL COLON COLORECTAL Test
Components *Microsatellite Instability Panel *KRAS*BRAF*PIK3CA*PTEN
Price 2970.0 AED
Sample Condition Submit Formalin fixed paraffin embedded tissue block. Ship at room temperature.Tissue block must contain at least 10% tumor tissue. Duly filled NGS Test Requisition Formis mandatory.
Report Delivery Sample Tue by 9 am; Report 10 Workingdays
Method Immunohistochemistry, NGS
Test type Cancer
Doctor Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Duly filled NGS Test Requisition Formis mandatory.
Test Details

The Cancer Targeted Gene Panel: Colon/Colorectal Test is a genetic test that analyzes specific genes associated with colon and colorectal cancer. It is used to identify mutations or alterations in these genes that may increase an individual’s risk of developing these types of cancer.

This test typically examines a panel of genes that are known to be involved in the development and progression of colon and colorectal cancer. These genes may include APC, KRAS, BRAF, PIK3CA, and others. By analyzing these genes, the test can provide information about the presence of specific mutations or alterations that may be linked to an increased risk of developing colon or colorectal cancer.

The results of this test can help healthcare providers make more informed decisions regarding an individual’s risk of developing these types of cancer. It can also guide treatment options and provide valuable information for personalized medicine approaches.

It is important to note that this test is typically performed on individuals who have a personal or family history of colon or colorectal cancer, or those who have other risk factors for these types of cancer. It is not a screening test for the general population.

As with any genetic test, it is recommended to discuss the potential benefits, limitations, and implications of the test with a healthcare provider or genetic counselor before undergoing testing.